PDT Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-21,454
| Closed | -$98K | – | 847 |
|
|
2021
Q2 | $98K | Sell |
21,454
-5,106
| -19% | -$23.3K | 0.01% | 764 |
|
|
2021
Q1 | $156K | Buy |
+26,560
| New | +$156K | 0.01% | 720 |
|
|
2020
Q2 | – | Sell |
-170,500
| Closed | -$332K | – | 752 |
|
|
2020
Q1 | $332K | Buy |
+170,500
| New | +$332K | 0.03% | 456 |
|
|
2019
Q3 | – | Sell |
-142,600
| Closed | -$897K | – | 468 |
|
|
2019
Q2 | $897K | Sell |
142,600
-28,646
| -17% | -$180K | 0.05% | 263 |
|
|
2019
Q1 | $952K | Buy |
171,246
+16,745
| +11% | +$93.1K | 0.05% | 266 |
|
|
2018
Q4 | $1.03M | Sell |
154,501
-54,498
| -26% | -$362K | 0.06% | 270 |
|
|
2018
Q3 | $2.23M | Sell |
208,999
-29,300
| -12% | -$313K | 0.09% | 229 |
|
|
2018
Q2 | $2.86M | Buy |
238,299
+1,099
| +0.5% | +$13.2K | 0.11% | 214 |
|
|
2018
Q1 | $2.03M | Sell |
237,200
-897
| -0.4% | -$7.69K | 0.07% | 270 |
|
|
2017
Q4 | $2.35M | Buy |
+238,097
| New | +$2.35M | 0.07% | 276 |
|
|
2015
Q3 | – | Sell |
-20,845
| Closed | -$168K | – | 1441 |
|
|
2015
Q2 | $168K | Buy |
+20,845
| New | +$168K | ﹤0.01% | 1259 |
|